ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 262 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $268 | -63.6% | 12,873 | -67.1% | 0.03% | -60.3% |
Q1 2023 | $736 | -99.8% | 39,075 | +80.8% | 0.07% | +94.3% |
Q3 2022 | $354,000 | -63.9% | 21,618 | -46.6% | 0.04% | -69.8% |
Q1 2022 | $981,000 | +371.6% | 40,490 | +374.1% | 0.12% | +452.4% |
Q2 2021 | $208,000 | -39.9% | 8,540 | +19.7% | 0.02% | -59.6% |
Q2 2020 | $346,000 | +8.5% | 7,137 | -4.4% | 0.05% | +2.0% |
Q4 2019 | $319,000 | -20.1% | 7,465 | -32.7% | 0.05% | -27.1% |
Q3 2019 | $399,000 | +94.6% | 11,087 | +44.6% | 0.07% | +100.0% |
Q2 2019 | $205,000 | -28.8% | 7,667 | -57.0% | 0.04% | -30.0% |
Q4 2018 | $288,000 | – | 17,815 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |